Remove pharma top-10-vaccine-companies-worldwide
article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Vaccines 108
article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

Shots: Integrating scintigraphy with therapeutics, radiopharmaceutical companies have emerged profoundly in the past few decades. With the growing influence of radiopharmaceutical companies in oncology, the companies hold a firm grasp on the market. threshold by 2026. threshold by 2026.

FDA 56
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

Reports of contaminated products from multiple sources worldwide were gathered to review overall trends and identify challenges. Microbial Contaminants From 2007 to 2021, 90 cases of contamination due to microorganisms were reported, with 61 caused by bacteria, 5 , 6 , 7 , 8 , 9 , 10 , 23 by viruses, 11 , 12 and 6 by fungi.

article thumbnail

Digitalisation of the clinical trial landscape

European Pharmaceutical Review

With the adoption of digital technologies gaining traction in many industries, pharmaceutical companies must take advantage of digitalisation within its research and development (R&D) sector. Why R&D innovation holds the key to greater patient impact What are the top two benefits of a single digital clinical data library?

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

These new operating models can help enable and accelerate the efforts of Pharma 4.0â„¢ 10 Similarly, POC manufacturing describes production at or near the location of the patient. Fit for use is a critical factor that companies must evaluate when selecting a manufacturing operating model. â„¢ technologies.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.